Author

Anthony R. Martin

École Nationale Supérieure de Chimie de MontpellierORCID 0000-0001-6187-6979Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Adèle RivaultiD· 1 shared Alain ChavanieuiD· 1 shared Alban Vigroux· 1 shared Arnaud JacqueliD· 1 shared Arnaud PoterszmaniD· 1 shared Baptiste LegrandiD· 1 shared Catherine BirckiD· 1 shared Cécile Favreau· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Adèle RivaultORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryExperimental Hematology and OncologyPeer-reviewedMar 31, 2026

Dual targeting of GPX4 and TXNRD1 triggers eradication of AML cells through induction of apoptosis and ferroptosis

Cécile Favreau, Maxence Bourgoin, Coline Savy…·Guillaume Robert

The paper identifies two compounds that target GPX4 and TXNRD1 to induce apoptosis and ferroptosis in AML cells, effectively eradicating malignant cells while sparing normal hematopoietic cells.

DOI 10.1186/s40164-026-00766-4

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyOncogenesisPeer-reviewedAug 30, 2025

Targeting Pregnane X Receptor with a Potent Agonist-Based PROTAC to Delay Colon Cancer Relapse

Lucile Bansard, Guillaume Laconde, Vanessa Delfosse…·Jean‐Marc Pascussi

This study designs and tests a PXR agonist-based PROTAC (JMV7048) that degrades PXR in cancer cells, reducing chemoresistance and delaying colon cancer relapse.

8 citations

humanexperimental assay

𝕏 PostBluesky